Pancreatic and biliary tract cancers are fatal malignancies, with a limited number of diagnostics tools, or effective systemic treatments. We are seeking a motivated PhD candidate to join our research team dedicated to improve early diagnostic tool and overcome cancer resistance through the identification and functional analysis of novel biomarkers.
This project will focus on uncovering the molecular underpinnings of pancreatic ductal adenocarcinoma cancer (PDAC) and cholangiocarcinoma, utilizing cutting-edge technologies such as next-generation sequencing, advanced proteomics and pharmacological studies. You will investigate genetic and epigenetic alterations, non-coding RNAs, and protein interactions that contribute to metastasis and therapeutic resistance.
The ultimate aim is to develop diagnostic and predictive biomarkers as well as new potential therapeutic targets, enhancing the efficacy of cancer treatments and improving patient outcomes. To achieve these aims, we collaborate closely with surgeons, oncologists, pathologists, and a multidisciplinary team of scientists supporting translational research at Amsterdam UMC.
You will study the omics characteristics of PDAC and cholangiocarcinoma cells and tissues as well as in patient plasma, prior and during treatment. In addition, you will participate in investigating clinical data which can improve diagnosis or predict treatment outcome.
If you are passionate about translational cancer research and aspire to make a significant impact, we encourage you to apply for this exciting opportunity.
Project-related tasks include:
- Omics and imaging analysis of tissues and liquid biopsy samples;
- In vitro experiments on the interactions between cancer and host cells;
- In vitro experiments on new drugs/combinations;
- Maintain accurate and detailed records of experiments;
- Data analyses and preparation of scientific publications;
- Co-supervision of trainees and students.